Ernest Waaser

Chief Executive Officer

Ernest Waaser é stato nominato come amministratore delegato e membro del consiglio di amministrazione della Systagenix Wound Management nel giugno 2011.

Prima di entrare in Systagenix era presidente della Teleflex Medical  azienda fornitrice di prodotti usa e getta per accessi vascolari, respiratori, urologia, anestesia e applicazioni chirurgiche. Ancora prima di Teleflex Waaser ha ricoperto la posizione di presidente e amministratore delegato del Hill-Romun, azienda fornitrice globale di letti ospedalieri e prodotti terapeutici per la cura di ferite e  dell’apparato respiratorio. Inoltre Waaser ha avuto un’esperienza di oltre 10 anni nel settore radiologico ricoprendo il ruolo di dirigente di servizio di Sterling  Diagnostic Imaging una branca di successo del patrimonio privato di Du pont.

Waaser ha una laurea in ingegneria nucleare alla Mississippi State University e un master in ingegneria meccanica all’ University of South Carolina.

Joseph Woody

Non Executive Director

Joe Woody, Presidente di  Vascular Therapies è responsabile di tutto il portfolio dei prodotti vascolari costituito da 3 categorie di prodotti: Vascolare venoso (cateteri per dialisi, congegni per la compressione; Trombosi venosa profonda; sistemi per l’intervento e  prevenzione dell’ insufficienza venosa cronica); Vascolare periferico (stents arteriosi periferici; palloncini e aterectomia); Neurovascolare (aneurisma cerebrale spirale embolica  ed deviazione di flusso, trombectomia e embolici liquidi). Woody è stato strumentale nell’acquisizione di EV3, una società del valore di 450mil  di dollari specializzata nel trattamento delle malattie vascolari periferiche e neurovascolari. Woody è entrato a far parte di Covidien nel  maggio del 2009 dopo aver ricoperto posizioni di crescente responsabilità in Smith & Nephew, Inc.; Alliance Imaging, Inc.; EMC, Acuson e General Electric Medical Systems. Si è laureato a Fullerton, Università statale della California.

Christopher M.Fashek

Non-Executive Director

Christopher Fashek ha acquisito una vasta esperienza nel mercato della cura delle lesioni, ed ha ricoperto tra l'altro l'incarico di Presidente e Vice Presidente di Kinetic Concepts Inc (KCI) USA dal 1995 al 2007. È inoltre riconosciuto a livello internazionale per aver pilotato con successo durante il suo mandato l'introduzione e la significativa crescita negli Stati Uniti di V.A.C™, una terapia a pressione negativa per la cura delle lesioni.

Prima di arrivare in KCI nel 1995, ha ricoperto l'incarico di General Manager, presso la sede di Sterling Winthrop in Nuova Zelanda e di Vice Presidente delle Vendite presso la sede di Sterling Winthrop negli Stati Uniti, una ex divisione della Eastman Kodak. Ha poi lavorato con una serie di società startup nel settore della cura delle lesioni, ha fatto parte del consiglio di amministrazione di varie società nel campo dell'assistenza sanitaria e di fondazioni caritatevoli, oltre ad aver partecipato in qualità di oratore ed esperto a numerose conferenze nel campo dell'assistenza sanitaria.

Fashek ha conseguito una laurea (Bachelor of Arts) in Storia presso il College di Usala di East Orange, in New Jersey, e un master in amministrazione aziendale (Master of Business Administration) presso la Fairleigh Dickinson University di East Rutherford, New Jersey.

Christian Ahrens

Non-Executive Director

Chris Ahrens è Managing Director di One Equity Partners (OEP). Prima di arrivare alla OEP nel 2001, ha lavorato per Goldman Sachs.Attualmente, fa parte del Consiglio di Amministrazione di Carlson Wagonlit, Travel Acquisitions Group e Vertrue. Ha inoltre conseguito la laurea (Bachelor of Arts) in Storia europea moderna presso l'Università di Princeton.

Greg Belinfanti

Non-Executive Director

Il Dottor Belinfanti è Managing Director di One Equity Partners (OEP). Prima di arrivare in OEP, ha ricoperto l'incarico di Vice Presidente della divisione Investment Banking di Lehman Brothers, specializzandosi in Assistenza sanitaria globale.

Fa inoltre parte del Consiglio di Amministrazione di Apollo Health Street e del Gruppo Prodigy Health. Ha conseguito il Bachelor of Arts in Politica presso l'Università di New York e una doppia laurea (Joint Degree) presso l'Università di Harvard.

Brad Coppens

Non-Executive Director

Il Dottor Coppens è Managing Director di OEP. Prima di arrivare in OEP nel 2006, ha lavorato nella divisione Investment banking di JPMorgan Chase & Co, nel dipartimento fusioni e acquisizioni.

Attualmente fa parte del consiglio di amministrazione del gruppo Prodigy Health, di Systagenix Wound Management e di X-Rite. Il Dottor Coppens ha conseguito una laurea (Bachelor of Business Administration) in contabilità e finanza presso la Ross School of Business dell'Università del Michigan.

Gordie Nye

Non-Executive Director

Gordie Nye è attualmente Managing Director di Group Outcome, LLC, nonché CEO di Zeltiq Aesthetics. In precedenza, ha ricoperto l'incarico di CEO di REVA Medical nonché di Presidente e CEO di due ex divisioni di Johnson & Johnson – "A" Company Orthodontics e Critikon dopo essere state acquisite tramite rilevazione con capitale di prestito. Durante il suo mandato, ha eseguito delle revisioni complete su tutta la linea di prodotti prima della loro eventuale vendita rispettivamente a Sybron International (facente attualmente parte di Danaher) e GE Medical Systems.

Nel 2003, il Dottor Nye è arrivato alla Prism VentureWorks in qualità di General Partner presso la sua equipe di investimento in scienze della vita, concentrandosi sui presidi medici. Per tutto questo periodo, è stato membro del Consiglio di Amministrazione di varie società facenti parte del portafoglio di Prism. Ha inoltre trascorso circa 15 anni nel comparto Consumer packaged goods & leisure ricoprendo vari incarichi nel settore marketing, vendite e direzione generale per società quali Gillette, Olin Ski Company, Reebok e L.A. Gear.

Il Dottor Nye ha conseguito un master in amministrazione aziendale (Master of Business Administration) presso la Amos Tuck School of Business del Dartmouth College,  dove aveva in precedenza conseguito anche il diploma di laurea.

Bob Stockman

Non-Executive Director

Bob Stockman è attualmente Presidente del Consiglio di Amministrazione di REVA Medical, una società produttrice di presidi medici che sta sviluppando un nuovo stent riassorbile che eluisce un farmaco. È inoltre Presidente e fondatore di Group Outcome LLC, una società di merchant banking con sede negli Stati Uniti che mette a frutto il proprio capitale e quello dei suoi partner finanziari in investimenti private equity e venture di società che sviluppano tecnologie mediche.

Il Dottor Stockman ha anche co-fondato e fornito il finanziamento di avviamento di CentriMed, oggi conosciuta come Global HealthCare Exchange, società leader per lo scambio elettronico di forniture per ospedali. Assieme ai suoi partner è stato poi fondatore e CEO di oltre 16 società di successo nel campo dei prodotti medici.

Prima di arrivare in Group Outcome LLC, ha trascorso 18 anni presso Johnston Associates e Narragansett Capital Corporation, dove si è concentrato sulle transazioni nel campo dell’assistenza sanitaria. Il Dottor  Stockman è stato inoltre membro del consiglio di amministrazione di una serie di altre società in campo sanitario. Ha conseguito un master in amministrazione aziendale (Master of Business Administration) presso la Amos Tuck School di Dartmouth e una laurea (Bachelors degree) presso l’Harvard College.

Jack Wilkens

Non-Executive Director

Jack Wilkens è il Chief Executive Officer di  RevDia Corporation a Miami. RevDia specializes in infectious disease point of care diagnostic testing and ha lanciato recentemente un test per la malattie parodontale. Prima di arrivare a RevDia Jack era Chief Operating Officer alla Inverness Medical Innovations (ora Alere – ALR-NYSE). IMI è la società leader mondiale nel POC con vendide superiori a $ 1.9 miliardi e leader mondiale nella diagnostica delle patologie femminili. Prima della carica COO, J. Wilkens è stato direttore Generale di Unipath di proprietà dell’IMI, Inc a Bedford, Inghilterra. Durante questo periodo è stato responsabile del settore del Women's Health diagnostics ed ha condotto il lancio mondiale del primo test di gravidanza digitale nel mercato consumer. E’ stato Direttore Generale del sito operativo dell’IMI e Johnson & Johnson a Inverness in Scozia e responsabile Europeo delle vendite. Il sito scozzese ha sviluppato prodotto e lanciato il monitor per il controllo del glucosio nel sangue. Jack è stato VicePresident del Medical Imaging Systems con Sterling Diagnostics/AGFA, responsabile dei sistemi radiografici e della piattaforma delle immagini digitali. Ha anche lavorato alla Polaroid per molti anni occupandosi della produzione, sviluppo del prodotto e marketing della diagnostica per immagini. E’ stato responsabile della progettazione la costruzione e sito operativo della Polaroid e impegnato nella progettazione, sviluppo e marketing di molti sistemi nel campo dell’istant imaging. Jack Wilkens ha un BS in Chemical Engineering conseguito alla Michigan State University ed un MBA al Western New England College.

Oern R. Stuge

Non-Executive Director

Oern R. Stuge è il fondatore di ORSCO Life Sciences AG, dove attualmente riveste molte cariche direttive e consultive incluso Mediq NV, Nobel Biocare AG, Impulse Dynamics NV, Bonesupport AB, Quentiq AG, Aleva SA, HealthCap AB.
E’ stato nominato nel Consiglio da Amministrazione di Systagenix nell’ottobre 2011. Dr. Stuge ha maturato 12 di esperienza nella Medtronic Inc. in diverse posizioni incluso Senior Vice President & President Cardiac Surgery, President EMEA, Latin America, Canada & India, membro del Executive Committee e dell’Operating Committee. Più recentemente ha maturato 6 anni di esperienza alla Abbott Laboratories, 7 anni ad uno startup norvegese, inclusa la posizione di CEO e 6 anni come medico praticante. Si è laureato all’Università di Oslo e ha conseguito l’MBA all’IMD in Svizzera.

Rob Snyder

Certified Wound Specialist

Medical Director, Systagenix; Diplomat, American Board of Podiatric Surgery; Fellow, American College of Foot & Ankle Surgery; Certified Wound Specialist; Medical Director, Wound Healing Centre, University Hospital, Tamarac, Florida; Clinical Professor (Adjunct), Temple University College of Podiatric Medicine; Diplomat, American Academy of Wound Management; serves on the board of directors, President of the American Academy of Wound Management and President elect of the Association for the Advancement of Wound Care

Dr. Robert Snyder has been a podiatrist for 30 years; for the past 12 years, he has dedicated his practice to wound management and limb salvage. Dr. Snyder is a diplomat of the American Board of Podiatric Surgery and a Fellow of the American College of Foot and Ankle Surgeons. Additionally, he holds diplomat status in the American Academy of Wound Management, is a Certified Wound Specialist, and serves on the board of directors of that organization. He also serves on the board of directors of the Association for the Advancement of Wound Care.

He is currently completing a graduate degree in Wound Healing and Tissue Repair from Cardiff University, Wales College of Medicine, UK. Dr. Snyder has also been appointed Clinical Professor (Adjunct) at Temple University School of Podiatric Medicine.

Dr. Snyder serves as Medical Director of the Wound Care Center at University Hospital, Tamarac, Florida and was Medical Director of the Wound Healing Center at Northwest Medical Center, Margate, Florida. Dr. Snyder also serves as Medical Director of Systagenix Wound Management.

Dr. Snyder lectures extensively throughout the United States and abroad, and has published several book chapters and more than 75 articles in peer reviewed and trade journals. He serves on the editorial advisory boards of Ostomy Wound Management and Podiatry Management, and has recently been appointed as a reviewer for the New England Journal of Medicine. Dr. Snyder performs research concerning many innovative wound healing modalities and products. He was honored with the DuoDerm Research Scholarship in 1999 and studied at the Wound Healing Summer School at Oxford University, UK.

Dr. Snyder was recently designated a "Heavy Hitter in Medical Specialty Care" by the South Florida Business Journal. In October 2006, Podiatry Management acknowledged Dr. Snyder as one of "America's 175 Most Influential Podiatrists".

7301 N. University Drive, Suite 305
Tamarac, Florida 33321
(954) 721-4806 Tel
(954) 721-9841 Fax

David G. Armstrong

DPM,PhD

DPM, PhD: Professor of Surgery (with Tenure), University of Arizona; co-founded the Southern Arizona Limb Salvage Alliance; founder and co-chair of the International Diabetic Food Conference

Dr. Armstrong is Professor of Surgery (with Tenure) at The University of Arizona. Dr. Armstrong also holds a Masters of Science in Tissue Repair and Wound Healing from the University of Wales College of Medicine and a PhD from the University of Manchester College of Medicine, where he was appointed Visiting Professor of Medicine. He also co-founded the Southern Arizona Limb Salvage Alliance (SALSA).

Dr. Armstrong has produced more than 270 peer-reviewed research papers in more than two dozen scholarly medical journals as well as over two dozen book chapters and is co-Editor of the American Diabetes Association's (ADA) Clinical Care of the Diabetic Foot.

Dr. Armstrong was selected as one of the first six International Wound Care Ambassadors and is the recipient of numerous awards by national and international medical organizations including the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage. In 2008, he was the 25th and youngest-ever member elected into the Podiatric Medicine Hall of Fame.

Dr. Armstrong is past Chair of Scientific Sessions for the ADA's Foot Care Council, and a past member of the National Board of Directors of the American Diabetes Association as well as a former commissioner with the Illinois State Diabetes Commission. He sits on the Infectious Disease Society of America's Diabetic Foot Infection Advisory Committee. Dr. Armstrong is the founder and co-chair of the International Diabetic Foot Conference (OF-Con), the largest annual international symposium on the diabetic foot in the world.

Matthias Augustin

Prof. Dr Med.

Professor for Health Economics & QoL Research Group, Department of Dermatology, University Clinics of Hamburg, Germany

Laura Bolton

PhD

PhD: Adjunct Associate Professor of the Department of Surgery, Bioengineering Section, New Jersey, USA; member of Editorial Boards of Wound Repair and Regeneration, Ostomy/Wound Management, Advances in Skin & Wound Care & WOUNDS publications; co-chairs the Association for the Advancement of Wound Care Guideline Department

Laura’s involvement in wound healing began in 1974 as a scientist for Johnson & Johnson conducting research on moist wound healing, growth factors, antimicrobials and electrical stimulation, with a dual role as biologist and educator starting in 1981 at the University of Medicine and Dentistry of New Jersey Department of Surgery, Bioengineering Section where she now serves as Adjunct Associate Professor of the Department of Surgery.

In 1987 Laura joined ConvaTec to lead the team that developed the DuoDERM CGF family of dressings using an evidence-based product development approach. In addition to evaluating new technologies and organizing wound care symposia on wound infection and cost effective wound care she has given more than 60 continuing education and Grand Rounds lectures at symposia, medical facilities and universities throughout North and South America, Asia, Europe and the Middle East and published more than 100 articles in peer-reviewed wound journals.

As a member of the Editorial Boards of Wound Repair and Regeneration, Ostomy/Wound Management Advances in Skin and Wound Care (Distinguished Reviewer Award, 2004) and WOUNDS (Guest Editor for the May 1994 and November 2007 issues addressing Outcomes in Wound Management and author of the bimonthly "Evidence Corner") Laura mentors current and future wound care clinicians and scientists.

In 2001, Laura was honored with the Sharon Baranoski Founder's Award at the 16th Annual Clinical Symposium for Advances in Skin Care and Wound Care for a career of mentoring and educating colleagues in wound care. The Journal of Wound Ostomy Continence Nurses, where Laura has contributed several "Evidence-based Report Cards", awarded her coauthors and herself the Nursing 2005 Manuscript Award for our 2004 article "Wound Healing Outcomes Using Standardized Care."

In January, 2006, Laura retired as ConvaTec's Global Director of Scientific Affairs.

Currently Laura co-chairs the Association for the Advancement of Wound Care Guideline Department and serves on the Guideline Steering Committee for the World Health Organization Global Initiative on Wound and Lymphoedema Management.

Laura is a member of the Boards of Directors for the Wound Healing Society and C3: Continuum of Care Coalition and is Chief Scientific Advisor for Derma Sciences. Her consulting company, BoltonSCI, LLC, exists to encourage evidence-based wound and ostomy care practices, product development and marketing.

Franck Duteille

Prof.

MD: Head of Department of Plastic Reconstructive and Esthetic Surgery, University Hospital, Nantes, France

Dieter Mayer

Prof.

MD: Vascular Surgeon, EBSQ-VASC, FMH; Senior Consultant of Vascular Surgery & Head of Wound Care, Zurich University Hospital, Switzerland

Dr. Zena Moore

PhD, MSc, FFNMRCSI, PG, Dip, RGN

PhD, MSc, FFNMRCSI, PG Dip, RGN: Lecturer in Wound Healing & Tissue Repair & Research Methodology, Faculty of Nursing & Midwifery, Royal College of Surgeons in Ireland; Current President of European Wound Management Association and chair of the education committee

Dr. Moore is a registered nurse, from Dublin, Ireland, and has just completed her PhD studies' exploring repositioning for the prevention of pressure ulcers; this 3 year research programme was funded by a Clinical Research Fellowship from the Health Research Board of Ireland. Before undertaking her PhD, Dr. Moore was a lecturer at the Faculty of Nursing and Midwifery, Royal College of Surgeons in Ireland, where she coordinated the Post Graduate Diploma/MSc in Wound Management & Tissue Viability programme. Previous to taking up the post as a lecturer, Dr. Moore worked in the area of wound management and tissue viability for 11 years.

Dr. Moore received a post graduate diploma, with distinction, in wound healing & tissue repair from the University Of Wales College Of Medicine in 1998 and an MSc in wound healing & tissue repair in 2001 from the same university. In 2002 she received a Fellowship of the Faculty of Nursing & Midwifery, RCS.

Dr. Moore is actively involved in research in wound management and has undertaken a number of systematic reviews with the Cochrane wounds group and the Cochrane renal group. Furthermore, Dr. Moore has published over 55 articles and book chapters and has researched in many aspects of wound management which have been presented at local, national and international meetings.

Dr. Moore is a member of the Health Service Executive of Ireland's National Wound Management Guideline Development group and was also a member of the 2009 European Pressure Ulcer Advisory Panel/National Pressure Ulcer Advisory Panel pressure ulcer prevention and management guideline development group.

Dr. Moore is president of the European Wound Management Association, where she also chairs the education committee.

Dr. Moore is a member of the World Health Organisation's Global Initiative in Wound and Lymphoedema Care and a member of EUCOMED advanced wound care sector.

Prof. Marco Romanelli

MD, PhD

MD, PhD: Consultant Dermatologist, Department of Dermatology, University of Pisa, Italy; Director Wound Healing Research Unit, University of Pisa; leads a research group actively involved in clinical, laboratory and educational activities

Dr. Marco Romanelli is a Board certified, Consultant Dermatologist at the Department of Dermatology, University of Pisa and received a PhD in Experimental Dermatology from the University of Naples. He is currently director of the Wound Healing Research Unit within the University of Pisa in Italy and leads a research group actively involved in clinical, laboratory and educational activities.

He is founding member and Past-President and board member of the European Pressure Ulcer Advisory Panel (EPUAP). He is currently Immediate Past President and Council member of the European Wound Management Association (EWMA), Executive Board member of the World Union Wound Healing Society (WUWHS). He is also Past President of the Italian Association for Cutaneous Ulcer (AIUC).

He has a special interest in wound assessment using physical measurements, inflammatory ulcers, biochemical markers in wound healing and has published widely in this field, in which he continues to undertake research.

Dr. Romanelli is on the editorial board of the journals WOUNDS, Wound Repair and Regeneration, The International Journal of Lower Extremity Wounds, Journal of Wound Care, International Wound Journal, Acta Vulnologica & Journal of Tissue Viability Nurses Society.

Dr. Thomas E. Serena

MD, FACS, FACHM, FAPWCA

MD, FACS, FACHM, FAPWCA: Founder & Medical Director of Pennsylvania North Centers for Advanced Wound Care, USA; founder of the NewBridge Medical Research Corporation and emeritus member of the Board of Director of the Wound Healing Society

He completed his residency in Surgery at The Milton S. Hershey Medical Center with fellowship training in Plastic and Reconstructive Surgery at Southern Illinois University. He is a professor at Gannon University in Erie Pennsylvania where he has established a state-of-the-art research program including development of a novel acute wound-healing model.

To date he has opened and operates fourteen wound care centers from New York City to Tulsa Oklahoma. Dr. Serena has been the lead or Principal investigator in over 50 clinical trials, including testing blood platelets, antimicrobial dressings, growth factors, topical and parenteral antibiotics and bi-Iayered cell therapy. As a result of the overwhelming demand for his services as a researcher, he founded the NewBridge Medical Research Corporation, a non-profit corporation (501(c) 3) dedicated to advancing the science of wound healing.

He is recognized internationally as an expert in the field of wound healing: He has nearly 100 published papers and has given more than 200 invited lectures throughout the world. He consults for numerous wound care industrial partners in the development of new products for the wound care space. He is an emeritus member of the Board of Directors of the Wound Healing Society and recently was an author on four of the national guidelines for the treatment of chronic wounds. More recently he was elected Vice President of the American College of Hyperbaric Medicine. He is also on the board of directors of the Association for the Advancement of Wound Care.

R. Gary Sibbald

BSc, MD FRCPC (Med, Derm), MACP, FAAD, MEd, FAPWCA

Dr. Sibbald is a dermatologist and internist with a special interest in wound care and education. He is a professor of public health sciences and medicine at the University of Toronto. As a wound care educator, clinician and clinical researcher he is an international wound care key opinion leader.

Dr. Sibbald is the co-founder (1999) and course director of the International Interprofessional Wound Care Course (IIWCC). He is the director of the Masters of Science in Community Health (Prevention and Wound Care) at the Della Lama School of Public Health at University of Toronto.

Dr. Sibbald is the president of the World Union of Wound Healing Societies 2008-12.
He is a co-editor and chapter author of the Chronic Wound Care textbook with the 5th edition due in 2010. He has over 200 publications.

Dot Weir

RN, CWON, CWS

RN, CWON, CWS: Director of Wound Care for Osceola Regional Medical Center, Florida, USA; held posts of Treasurer & President of Association for Advancement of Wound Care

Dot is a registered nurse, received her wound certifications from the Wound, Ostomy and Continence Nurses Certification Board, and the American Academy of Wound Management, and has been practicing wound care since 1980. She has worked in acute care, long term and home care, and for the past 8 years has practiced in outpatient care. She is currently the Director of Wound Care for Osceola Regional Medical Center in Kissimmee, Florida.

Dot was a founding member and has held the office of Treasurer and President of the Association for the Advancement of Wound Care (MWC), and is also a member of the Wound Healing Society (WHS), the Wound, Ostomy and Continence Nurses Society (WOCN) and the Florida Association of Enterostomal Therapists (FAET). She is the Co-Chair of the Symposium on Advanced Wound Care, is co-editor of the journal Today's Wound Clinic, is on the faculty of the Wound Certification Prep Course, and is a consultant and speaker for several manufacturers. She has authored and co-authored multiple book chapters and articles on various aspects of wound care.

Thomas Wild

MD

MD: Department of Surgery, University of Vienna, Austria; President Elect of Austrian Wound Association

Ernest Waaser

Chief Executive Officer

Ernest Waaser é stato nominato come amministratore delegato e membro del consiglio di amministrazione della Systagenix Wound Management nel giugno 2011.

Prima di entrare in Systagenix era presidente della Teleflex Medical  azienda fornitrice di prodotti usa e getta per accessi vascolari, respiratori, urologia, anestesia e applicazioni chirurgiche. Ancora prima di Teleflex Waaser ha ricoperto la posizione di presidente e amministratore delegato del Hill-Romun, azienda fornitrice globale di letti ospedalieri e prodotti terapeutici per la cura di ferite e  dell’apparato respiratorio. Inoltre Waaser ha avuto un’esperienza di oltre 10 anni nel settore radiologico ricoprendo il ruolo di dirigente di servizio di Sterling  Diagnostic Imaging una branca di successo del patrimonio privato di Du pont.

Waaser ha una laurea in ingegneria nucleare alla Mississippi State University e un master in ingegneria meccanica all’ University of South Carolina.

David Milner

Chief Financial & Operating Officer

David Miler si è unito a Systagenix nel 2008. Ha più di 25 anni di  carriera in Finanza e Impresa.  Prima di unirsi a Systagenix ha ricoperto una serie di posizioni  esecutive in diverse compagnie private sponsorizzate , inlcuse Critikon, “A” Company Orthodontics, Environmental Lighting Concepts, Voit Sports and BioSafety. Ha un  Master in Accountancy  all’ Universita’ dell’Indiana ed certificato come revisore contabile

Paolo Di Vincenzo

Vice President Global Marketing

Prima di unirsi a Systagenix Paolo di Vincenzo era Marketing director per il mercato Europeo per La Becton Dickinson Diagnostic (BD), leader mondiale di prodotti e strumenti utilizzati per la diagnosi delle malattie infettive.   Prima di unirsi al BD nell 2008, Paolo  De Vincenzo era  Country manager per la Roche Diagnostic, Cura del Diabete per il Portogallo e CRM Lead per Iberia ed America Latina, ricoprendo anche  una serie di ruoli senior internazionali e locali, in Marketing, Business Developent e Finance tra UK, Svizzera, Germania,  Stati Uniti e Singapore tra il 2001 e il 2008 che lo vedono con successo guidare il re-branding e rilancio di nuovi prodotti. Paolo di Vincezo ha conseguito la laurea all’Università’ di Brighton in UK e al Politecnico di Torino in Italia.

Helen Trevor

Vice President HR

Helen Trevor è il vice presidente delle risorse umane in Systagenix. Con oltre 20 anni di esperienza nelle risorse umane in diversi ruoli inclusi sindacati negli  stabilimenti industriali e servizi globali si supporto. Helen si è unita a Systagenix dopo aver lavorato per CR Bard in UK. Ha la laurea in Biologia e un master in gestione del personale.

Bill Pigg

Vice President Product Development And Quality

Bill Pigg, Vice Presisdente del  Product Development and Quality, e’ responsabile per la ricerca e sviluppo , regolamenti e assicurazione della qualità.  Ha una laurea ad honorem in Materials Science and Economics  con dottorato di ricerca  in materiale diversificato, Bill ha inoltre  un diploma in Medical Devise Innovation Management con  la Scandinavian International Management Institute (SIMI) a Copenhagen. Bill ha 20 anni di esperienza in ricerca e sviluppo dei dispositivi medici con società come Smith and Nephew, Johnson&Johnson e Systagenix, lavorando in diversi reparti come Surgical Gown and Drape, Surgical Gloves, Fracture Fixation e, maggior parte della sua carriera nella cura delle ferite. Billl ha lavorato in diversi ambienti lavorativi dalle associazioni per la ricerca ai centri di sviluppo corporativo  per lo sviluppo dei mercati e detiene diversi brevetti.

Jon Warrick

Vice Presidente, Mercati Internazionali

Jon è entrato in Systagenix nel 2008 come Vice Presidente del Global Marketing prima di assumere nel febbraio 2010 la sua attuale posizione con la responsabilità per le vendite internazionali al di fuori Stati Uniti e dell'Europa occidentale. Con 15 anni di esperienza nella gestione delle ferite in Johnson & Johnson e successivamente inSystagenix, Jon ha ricoperto diverse posizioni all'interno della Ricerca e Sviluppo, New Business Development, Marketing e Vendite Internazionali. Jon ha conseguito una laurea in Scienze Biomediche all'Università di Bradford e un MBA presso l’università di Leeds.